A Double-Blind, Multicenter Study to Assess the LDL-C Lowering of Combination Tablets Ezetimibe/Simvastatin (10mg/20mg) and Ezetimibe/Simvastatin (10mg/40mg) Compared to Atorvastatin 20 mg in Patients With Type II Diabetes.
Phase of Trial: Phase III
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Atorvastatin (Primary) ; Ezetimibe/simvastatin (Primary)
- Indications Hypercholesterolaemia; Lipid metabolism disorders
- Focus Therapeutic Use
- Sponsors Merck/Schering-Plough Pharmaceuticals
- 30 Aug 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History